|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$5,900
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$3,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$6,281
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$10,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$12,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$130,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$10,856
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$100,976
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$2,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$4,083
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
$65,844
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$86,567
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$4,974
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$800
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$14,806
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of FOXM1 as a new therapeutic target in high-risk myeloma
|
5R21CA187388-02
|
$165,844
|
$165,844
|
JANZ, SIEGFRIED
|
UNIVERSITY OF IOWA
|
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-03
|
$394,823
|
$394,823
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
|
Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma
|
5R33CA196470-02
|
$390,115
|
$390,115
|
LIN, QIAO
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$1,271
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$171,540
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
|
5R01CA180475-04
|
$347,390
|
$347,390
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$625
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$8,750
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$13,766
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
1R01CA211681-01
|
$504,721
|
$504,721
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S1
|
$60,000
|
$1,200
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S2
|
$125,000
|
$2,500
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S3
|
$241,905
|
$4,838
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S4
|
$101,773
|
$2,035
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S5
|
$253,858
|
$5,077
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-05
|
$2,107,000
|
$42,140
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
3P30CA023074-37S1
|
$75,000
|
$5,250
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
University of Arizona Cancer Center - Cancer Center Support Grant
|
5P30CA023074-37
|
$3,533,423
|
$247,340
|
KRAFT, ANDREW
|
UNIVERSITY OF ARIZONA
|
|
|
UM LAPs- U10 Grant
|
5U10CA180801-04
|
$803,208
|
$80,321
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
$14,819
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Ubiquitin signaling for protein degradation
|
ZIA BC 011490
|
$886,591
|
$797,932
|
Walters, Kylie
|
CCR (NCI)
|
|
|
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
|
5R01CA196831-03
|
$363,713
|
$363,713
|
JELINEK, DIANE
|
MAYO CLINIC ROCHESTER
|
|
|
Treatment of multiple myeloma using oncolytic myxoma virus
|
5R01CA194090-02
|
$341,981
|
$341,981
|
BARTEE, ERIC
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Translation of Novel Therapeutic Targets in Multiple Myeloma
|
5R01CA167511-05
|
$431,907
|
$431,907
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$950,432
|
$95,043
|
Larson, Daniel
|
CCR (NCI)
|
|
|
Toward identification of a family of novel NF-kB inducers
|
5R21CA194868-02
|
$160,854
|
$160,854
|
MIYAMOTO, SHIGEKI
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
|
5R01CA207237-02
|
$395,166
|
$395,166
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-03
|
$2,373,000
|
$71,190
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
The thrombospondin1-TGF-beta axis in multiple myeloma
|
5R01CA175012-04
|
$598,327
|
$598,327
|
MURPHY-ULLRICH, JOANNE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
|
5R01CA195732-02
|
$348,844
|
$174,422
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
|
The Role of MMP13 in Multiple Myeloma Bone Disease
|
5R01CA175313-04
|
$331,098
|
$331,098
|
LENTZSCH, SUZANNE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of Cereblon Pathways in Myeloma
|
5R01CA183968-04
|
$446,267
|
$446,267
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
Total relevant funding to Multiple Myeloma for this search: $60,746,955
|
